APA (7th ed.) Citation

Y, O., S, M., M, K., K, I., T, K., N, A., . . . S, Y. (2025). Prognostic impact and risk factors of severe neutropenia in the early phase of treatment with trifluridine-tipiracil for metastatic colorectal cancer patients: A single-center retrospective study. International journal of colorectal disease, 40(1), 11. https://doi.org/10.1007/s00384-024-04798-2

Chicago Style (17th ed.) Citation

Y, Omori, et al. "Prognostic Impact and Risk Factors of Severe Neutropenia in the Early Phase of Treatment with Trifluridine-tipiracil for Metastatic Colorectal Cancer Patients: A Single-center Retrospective Study." International Journal of Colorectal Disease 40, no. 1 (2025): 11. https://doi.org/10.1007/s00384-024-04798-2.

MLA (9th ed.) Citation

Y, Omori, et al. "Prognostic Impact and Risk Factors of Severe Neutropenia in the Early Phase of Treatment with Trifluridine-tipiracil for Metastatic Colorectal Cancer Patients: A Single-center Retrospective Study." International Journal of Colorectal Disease, vol. 40, no. 1, 2025, p. 11, https://doi.org/10.1007/s00384-024-04798-2.